Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Longevity Fund 2 LP — Decibel Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Longevity Fund 2 LP

Longevity Fund 2 LP

10% owner at Decibel Therapeutics, Inc. · on record since Feb 18, 2021

Insider trading activity of Longevity Fund 2 LP

Transactions on record: 2; since Feb 18, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 18, 2021

Figures computed from official regulatory filings — methodology.

Companies where Longevity Fund 2 LP has traded

Decibel Therapeutics, Inc.2 tx · Feb 18, 2021

Track record of Longevity Fund 2 LP

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Longevity Fund 2 LP

Co-insiders of Longevity Fund 2 LP

Decibel Therapeutics, Inc.
Carson William H.Decibel Therapeutics, Inc.
Casdin Partners Master Fund, L.P.Decibel Therapeutics, Inc.
Exter NeilDecibel Therapeutics, Inc.
FINGER ALISON CECILYDecibel Therapeutics, Inc.
Foy MatthewDecibel Therapeutics, Inc.
GLAXOSMITHKLINE PLCDecibel Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

GV 2016 GP, L.L.C.Decibel Therapeutics, Inc.

GV 2016 GP, L.P.Decibel Therapeutics, Inc.

GV 2016, L.P.Decibel Therapeutics, Inc.

GV 2017 GP, L.L.C.Decibel Therapeutics, Inc.

GV 2017 GP, L.P.Decibel Therapeutics, Inc.

GV 2017, L.P.Decibel Therapeutics, Inc.

GV 2019 GP, L.L.C.Decibel Therapeutics, Inc.

GV 2019 GP, L.P.Decibel Therapeutics, Inc.

GV 2019, L.P.Decibel Therapeutics, Inc.

Kapusta Matthew CDecibel Therapeutics, Inc.

Lee John Jui-JenDecibel Therapeutics, Inc.

Leiderman ElisabethDecibel Therapeutics, Inc.

LEVIN MARK JDecibel Therapeutics, Inc.

MCLAUGHLIN KEVIN FDecibel Therapeutics, Inc.

MURPHY JAMES BDecibel Therapeutics, Inc.

Nochur SaraDecibel Therapeutics, Inc.

ORBIMED ADVISORS LLCDecibel Therapeutics, Inc.

OrbiMed Capital GP VIII LLCDecibel Therapeutics, Inc.

ORBIMED CAPITAL LLCDecibel Therapeutics, Inc.

OrbiMed Genesis GP LLCDecibel Therapeutics, Inc.

POON CHRISTINE ADecibel Therapeutics, Inc.

REGENERON PHARMACEUTICALS INCDecibel Therapeutics, Inc.

Reid LaurenceDecibel Therapeutics, Inc.

Schroder Adveq cPl Global 2017 - 2019 C.V.Decibel Therapeutics, Inc.

Schroder Adveq cPl Global Management III L.P.Decibel Therapeutics, Inc.

Schroder Adveq Management Luxembourg SarlDecibel Therapeutics, Inc.

Schroder Adveq Technology IX S.C.S.Decibel Therapeutics, Inc.

STARR KEVIN PDecibel Therapeutics, Inc.

Steven H. Holtzman Revocable TrustDecibel Therapeutics, Inc.

TEPPER ROBERT IDecibel Therapeutics, Inc.

Third Rock Ventures GP III, L.P.Decibel Therapeutics, Inc.

Third Rock Ventures III, L.P.Decibel Therapeutics, Inc.

Thompson Peter ADecibel Therapeutics, Inc.

Trask AnnaDecibel Therapeutics, Inc.

TRV GP III, LLCDecibel Therapeutics, Inc.

Wong CynthiaDecibel Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Decibel Therapeutics, Inc.	Feb 18, 2021	Other	79,143	—	—	SEC
Decibel Therapeutics, Inc.	Feb 18, 2021	OtherD	-79,143	0.00 USD	$0	SEC